Manufacturing is crucial to the success of any drug development project but is too often overlooked. Dr. Andrea Cubitt, VP of External Scientific Alliances and Intellectual Property at aTyr Pharma, explains how her company has benefitted from the extensive experience that CDMO partner Lonza has developed in mAb manufacturing, including its rapid and cost-competitive DNA-to-IND Ibex® Design program, and manifestation of its strong reputation and track record in manufacturing expertise.
You may also be interested in:
Read this article

View now
Latest content
Latest briefing from the Knowledge Center